DUBLIN: Pfizer is to begin producing ingredients for its COVID-19 vaccine at an Irish facility, the US drugmaker said in a statement.

The plant, which will produce "mRNA drug substance" and employ 75 new staff, will be brought onto the network by the end of 2021 with an investment of up to $40 million, the statement said.